TRTH Application Procedure
The focus of the TRTH program is on laboratory-based translational research. Research projects must be hypothesis driven and directly connected to some aspect of human biology. Projects may encompass any form of cellular, molecular, structural, biochemical, genetic, or other appropriate experimental approach using human biological material or human subjects with the aim of reaching novel insights into human biology. Pilot and early phase clinical studies translating the laboratory discoveries "to the bedside" may be included in the proposal; however, pure clinical trial projects with laboratory correlatives will not be considered.
Proficiency in English is required.
How to apply
TRTH has a two-step application process which begins with submitting a Letter of Intent (LOI). Only selected applicants are invited to proceed to the second step of the application procedure. The applicant must be a member of EHA and/or ASH to be considered eligible for TRTH.
- Step 1: LOI
Submit your LOI & Applicant Information Form, CV, and project abstract by June 29, 2012. Those who are eligible will be invited to proceed to step 2 and submit a full application. The LOI submission file should be named as follows: LastName_FirstName-LOITRTH2013.pdf. (Example: Smith_Jane-LOITRTH2013.pdf) and should be sent to firstname.lastname@example.org.
- Step 2: Full Application
Eligible candidates invited to submit a full application must submit a comprehensive translational hematologic research project proposal and other required documents by September 5, 2012 to email@example.com.
For more information, please contact the EHA Executive Office at firstname.lastname@example.org.
Previous winners of the EHA-ASH Translational Research Training in Hematology